Blood storage conditions, age, and other factors can influence the levels of NfL, a nerve damage biomarker used in MS ...

Columnist Ben Hofmeister isn't as worried about his children inheriting MS as he is about them seeing the reality of living with the disease.

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Columnist Desiree Lama has always known she wanted to help people; now she is achieving that goal through MS advocacy.

Vaccination didn't increase the risk of children or adolescents being diagnosed with pediatric MS within five years, a study ...

Nabiximols and other cannabis-based treatments were seen to work well at controlling spasticity, though responses vary among ...

Tiziana Life Sciences is expanding its Phase 2 clinical trial testing foralumab nasal spray for the treatment of nonactive secondary progressive multiple sclerosis (SPMS), with six additional ...